{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:32:01Z","timestamp":1787679121230,"version":"build-2784847793"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s11302-018-9609-4","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T18:29:06Z","timestamp":1526495346000},"page":"235-243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington\u2019s disease"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5552-4061","authenticated-orcid":false,"given":"Maria Rosaria","family":"Domenici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Chiodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Averna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Armida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"P\u00e8zzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Pepponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Fuxe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Popoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"9609_CR1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","volume":"53","author":"BB Fredholm","year":"2001","unstructured":"Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527\u2013552","journal-title":"Pharmacol Rev"},{"key":"9609_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.110.003285","volume":"63","author":"BB Fredholm","year":"2011","unstructured":"Fredholm BB, IJzerman AP, Jacobson KA, Linden J, M\u00fcller CE (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update. Pharmacol Rev 63:1\u201334","journal-title":"Pharmacol Rev"},{"key":"9609_CR3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E","volume":"27","author":"P Svenningsson","year":"1997","unstructured":"Svenningsson P, Hall H, Sedvall G, Fredholm BB (1997) Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse 27:322\u2013335","journal-title":"Synapse"},{"key":"9609_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.pneurobio.2007.09.002","volume":"83","author":"JF Chen","year":"2007","unstructured":"Chen JF, Sonsalla PK, Pedata F, Melani A, Domenici MR, Popoli P, Geiger J, Lopes LV, de Mendonca A (2007) Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and \u201cfine tuning\u201d modulation. Prog Neurobiol 83:310\u2013331","journal-title":"Prog Neurobiol"},{"key":"9609_CR5","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.bbamem.2010.12.001","volume":"1808","author":"CV Gomes","year":"2011","unstructured":"Gomes CV, Kaster MP, Tome AR, Agostinho PM, Cunha RA (2011) Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochim Biophys Acta 1808:1380\u20131399","journal-title":"Biochim Biophys Acta"},{"key":"9609_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/WNF.0000000000000073","volume":"38","author":"T Kondo","year":"2015","unstructured":"Kondo T, Mizuno Y, Japanese Istradefylline Study Group (2015) A long-term study of istradefylline safety and efficacy in patients with Parkinson disease. Clin Neuropharmacol 38:41\u201346","journal-title":"Clin Neuropharmacol"},{"key":"9609_CR7","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1586\/14737175.2015.1113131","volume":"15","author":"RJ Vorovenci","year":"2015","unstructured":"Vorovenci RJ, Antonini A (2015) The efficacy of oral adenosine A(2A) antagonist istradefylline for the treatment of moderate to severe Parkinson\u2019s disease. Expert Rev Neurother 15:1383\u20131390","journal-title":"Expert Rev Neurother"},{"key":"9609_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1517\/14728222.2014.981529","volume":"19","author":"K Fuxe","year":"2015","unstructured":"Fuxe K, Guidolin D, Agnati LF, Borroto-Escuela DO (2015) Dopamine heteroreceptor complexes as therapeutic targets in Parkinson\u2019s disease. Expert Opin Ther Targets 19:377\u2013398","journal-title":"Expert Opin Ther Targets"},{"key":"9609_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.pneurobio.2006.12.005","volume":"81","author":"P Popoli","year":"2007","unstructured":"Popoli P, Blum D, Martire A, Ledent C, Ceruti S, Abbracchio MP (2007) Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington\u2019s disease. Prog Neurobiol 81:331\u2013348","journal-title":"Prog Neurobiol"},{"key":"9609_CR10","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.2174\/138161208784480117","volume":"14","author":"P Popoli","year":"2008","unstructured":"Popoli P, Blum D, Domenici MR, Burnouf S, Chern Y (2008) A critical evaluation of adenosine A2A receptors as potentially \u201cdruggable\u201d targets in Huntington\u2019s disease. Curr Pharm Des 14:1500\u20131511","journal-title":"Curr Pharm Des"},{"key":"9609_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/B978-0-12-801022-8.00010-6","volume":"119","author":"CF Lee","year":"2014","unstructured":"Lee CF, Chern Y (2014) Adenosine receptors and Huntington\u2019s disease. Int Rev Neurobiol 119:195\u2013232","journal-title":"Int Rev Neurobiol"},{"key":"9609_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10:204\u2013216","journal-title":"Nat Rev Neurol"},{"key":"9609_CR13","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1096\/fj.03-0079fje","volume":"17","author":"K Varani","year":"2003","unstructured":"Varani K, Abbracchio MP, Cannella M, Cislaghi G, Giallonardo P, Mariotti C, Cattabriga E, Cattabeni F, Borea PA, Squitieri F, Cattaneo E (2003) Aberrant A2A receptor function in peripheral blood cells in Huntington\u2019s disease. FASEB J 17:2148\u20132150","journal-title":"FASEB J"},{"key":"9609_CR14","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1523\/JNEUROSCI.23-12-05361.2003","volume":"23","author":"D Blum","year":"2003","unstructured":"Blum D, Galas MC, Pintor A, Brouillet E, Ledent C, Muller CE, Bantubungi K, Galluzzo M, Gall D, Cuvelier L, Rolland AS, Popoli P, Schiffmann SN (2003) A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists. J Neurosci 23:5361\u20135369","journal-title":"J Neurosci"},{"key":"9609_CR15","doi-asserted-by":"publisher","first-page":"11371","DOI":"10.1523\/JNEUROSCI.1907-06.2006","volume":"26","author":"QY Huang","year":"2006","unstructured":"Huang QY, Wei C, Yu L, Coelho JE, Shen HY, Kalda A, Linden J, Chen JF (2006) Adenosine A2A receptors in bone marrow-derived cells but not in forebrain neurons are important contributors to 3-nitropropionic acid-induced striatal damage as revealed by cell-type-selective inactivation. J Neurosci 26:11371\u201311378","journal-title":"J Neurosci"},{"key":"9609_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","volume":"93","author":"SY Chou","year":"2005","unstructured":"Chou SY, Lee YC, Chen HM, Chiang MC, Lai HL, Chang HH, Wu YC, Sun CN, Chien CL, Lin YS, Wang SC, Tung YY, Chang C, Chern Y (2005) CGS21680 attenuates symptoms of Huntington\u2019s disease in a transgenic mouse model. J Neurochem 93:310\u2013320","journal-title":"J Neurochem"},{"key":"9609_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nbd.2007.07.009","volume":"28","author":"MR Domenici","year":"2007","unstructured":"Domenici MR, Scattoni ML, Martire A, Lastoria G, Potenza RL, Borioni A, Venerosi A, Calamandrei G, Popoli P (2007) Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6\/2 Huntington\u2019s disease mice. Neurobiol Dis 28:197\u2013205","journal-title":"Neurobiol Dis"},{"key":"9609_CR18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.nbd.2010.09.021","volume":"41","author":"S Mievis","year":"2011","unstructured":"Mievis S, Blum D, Ledent C (2011) A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington\u2019s disease. Neurobiol Dis 41:570\u2013576","journal-title":"Neurobiol Dis"},{"key":"9609_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neulet.2007.02.034","volume":"417","author":"A Martire","year":"2007","unstructured":"Martire A, Calamandrei G, Felici F, Scattoni ML, Lastoria G, Domenici MR, Tebano MT, Popoli P (2007) Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington\u2019s disease versus wild-type mice. Neurosci Lett 417:78\u201383","journal-title":"Neurosci Lett"},{"key":"9609_CR20","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1100\/tsw.2010.164","volume":"10","author":"MT Tebano","year":"2010","unstructured":"Tebano MT, Martire A, Chiodi V, Ferrante A, Popoli P (2010) Role of adenosine A(2A) receptors in modulating synaptic functions and brain levels of BDNF: a possible key mechanism in the pathophysiology of Huntington\u2019s disease. ScientificWorldJournal 10:1768\u20131782","journal-title":"ScientificWorldJournal"},{"key":"9609_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog Neurobiol 81:294\u2013330","journal-title":"Prog Neurobiol"},{"key":"9609_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nlm.2006.05.004","volume":"87","author":"L Gimenez-Llort","year":"2007","unstructured":"Gimenez-Llort L, Schiffmann SN, Shmidt T, Canela L, Camon L, Wassholm M, Canals M, Terasmaa A, Fernandez-Teruel A, Tobena A, Popova E, Ferre S, Agnati L, Ciruela F, Martinez E, Scheel-Kruger J, Lluis C, Franco R, Fuxe K, Bader M (2007) Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain. Neurobiol Learn Mem 87:42\u201356","journal-title":"Neurobiol Learn Mem"},{"key":"9609_CR23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/jnc.13421","volume":"136","author":"V Chiodi","year":"2016","unstructured":"Chiodi V, Ferrante A, Ferraro L, Potenza RL, Armida M, Beggiato S, Pezzola A, Bader M, Fuxe K, Popoli P, Domenici MR (2016) Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors. J Neurochem 136:907\u2013917","journal-title":"J Neurochem"},{"key":"9609_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/mrd.10173","volume":"63","author":"E Popova","year":"2002","unstructured":"Popova E, Krivokharchenko A, Ganten D, Bader M (2002) Comparison between PMSG- and FSH-induced superovulation for the generation of transgenic rats. Mol Reprod Dev 63:177\u2013182","journal-title":"Mol Reprod Dev"},{"key":"9609_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/npp.2013.229","volume":"39","author":"V Chiodi","year":"2014","unstructured":"Chiodi V, Mallozzi C, Ferrante A, Chen JF, Lombroso PJ, Di Stasi AM, Popoli P, Domenici MR (2014) Cocaine-induced changes of synaptic transmission in the striatum are modulated by adenosine A2A receptors and involve the tyrosine phosphatase STEP. Neuropsychopharmacology 39:569\u2013578","journal-title":"Neuropsychopharmacology"},{"key":"9609_CR26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jneumeth.2006.12.018","volume":"162","author":"WW Anderson","year":"2007","unstructured":"Anderson WW, Collingridge GL (2007) Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions. J Neurosci Methods 162:346\u2013356","journal-title":"J Neurosci Methods"},{"key":"9609_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363","journal-title":"J Immunol Methods"},{"key":"9609_CR28","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1046\/j.1471-4159.1998.70020794.x","volume":"70","author":"E Brouillet","year":"1998","unstructured":"Brouillet E, Guyot MC, Mittoux V, Altairac S, Cond\u00e9 F, Palfi S, Hantraye P (1998) Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70:794\u2013805","journal-title":"J Neurochem"},{"key":"9609_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","volume":"59","author":"E Brouillet","year":"1999","unstructured":"Brouillet E, Conde F, Beal MF, Hantraye P (1999) Replicating Huntington\u2019s disease phenotype in experimental animals. Prog Neurobiol 59:427\u2013468","journal-title":"Prog Neurobiol"},{"key":"9609_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","volume":"1802","author":"M Damiano","year":"2010","unstructured":"Damiano M, Galvan L, Deglon N, Brouillet E (2010) Mitochondria in Huntington\u2019s disease. Biochim Biophys Acta 1802:52\u201361","journal-title":"Biochim Biophys Acta"},{"key":"9609_CR31","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1242\/dmm.017038","volume":"7","author":"S Apolloni","year":"2014","unstructured":"Apolloni S, Amadio S, Parisi C, Matteucci A, Potenza RL, Armida M, Popoli P, D'Ambrosi N, Volonte C (2014) Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis. Dis Model Mech 7:1101\u20131109","journal-title":"Dis Model Mech"},{"key":"9609_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0149-7634(96)00027-9","volume":"21","author":"CV Borlongan","year":"1997","unstructured":"Borlongan CV, Koutouzis TK, Sanberg PR (1997) 3-Nitropropionic acid animal model and Huntington\u2019s disease. Neurosci Biobehav Rev 21:289\u2013293","journal-title":"Neurosci Biobehav Rev"},{"key":"9609_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fpsyt.2014.00067","volume":"5","author":"JE Coelho","year":"2014","unstructured":"Coelho JE, Alves P, Canas PM, Valadas JS, Shmidt T, Batalha VL, Ferreira DG, Ribeiro JA, Bader M, Cunha RA, do Couto FS, Lopes LV (2014) Overexpression of adenosine A2A receptors in rats: effects on depression, locomotion, and anxiety. Front Psychiatry 5:67. https:\/\/doi.org\/10.3389\/fpsyt.2014.00067","journal-title":"Front Psychiatry"},{"key":"9609_CR34","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.neuropharm.2014.03.002","volume":"81","author":"J Jastrz\u0119bska","year":"2014","unstructured":"Jastrz\u0119bska J, Nowak E, Smaga I, Bystrowska B, Frankowska M, Bader M, Filip M, Fuxe K (2014) Adenosine (A)(2A)receptor modulation of nicotine-induced locomotor sensitization. A pharmacological and transgenic approach. Neuropharmacology 81:318\u2013326","journal-title":"Neuropharmacology"},{"key":"9609_CR35","doi-asserted-by":"publisher","first-page":"31493","DOI":"10.1038\/srep31493","volume":"6","author":"VL Batalha","year":"2016","unstructured":"Batalha VL, Ferreira DG, Coelho JE, Valadas JS, Gomes R, Temido-Ferreira M, Shmidt T, Baqi Y, Bu\u00e9e L, M\u00fcller CE, Hamdane M, Outeiro TF, Bader M, Meijsing SH, Sadri-Vakili G, Blum D, Lopes LV (2016) The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Sci Rep 6:31493. https:\/\/doi.org\/10.1038\/srep31493","journal-title":"Sci Rep"},{"key":"9609_CR36","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1471-4159.1993.tb05859.x","volume":"60","author":"E Brouillet","year":"1993","unstructured":"Brouillet E, Jenkins BG, Hyman BT, Ferrante RJ, Kowall NW, Srivastava R, Roy DS, Rosen BR, Beal MF (1993) Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neurochem 60:356\u2013359","journal-title":"J Neurochem"},{"key":"9609_CR37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0306-4522(00)00020-8","volume":"97","author":"S Ouary","year":"2000","unstructured":"Ouary S, Bizat N, Altairac S, Menetrat H, Mittoux V, Conde F, Hantraye P, Brouillet E (2000) Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies. Neuroscience 97:521\u2013530","journal-title":"Neuroscience"},{"key":"9609_CR38","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/jnr.22591","volume":"89","author":"S Mu","year":"2011","unstructured":"Mu S, OuYang L, Liu B, Zhu Y, Li K, Zhan M, Liu Z, Jia Y, Lei W, Reiner A (2011) Preferential interneuron survival in the transition zone of 3-NP-induced striatal injury in rats. J Neurosci Res 89:744\u2013754","journal-title":"J Neurosci Res"},{"key":"9609_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067658","volume":"8","author":"D Colle","year":"2013","unstructured":"Colle D, Santos DB, Moreira EL, Hartwig JM, dos Santos AA, Zimmermann LT, Hort MA, Farina M (2013) Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats. PLoS One 8:e67658. https:\/\/doi.org\/10.1371\/journal.pone.0067658","journal-title":"PLoS One"},{"key":"9609_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.brs.2012.03.015","volume":"6","author":"I Tasset","year":"2013","unstructured":"Tasset I, Perez-Herrera A, Medina FJ, Arias-Carrion O, Drucker-Colin R, Tunez I (2013) Extremely low-frequency electromagnetic fields activate the antioxidant pathway Nrf2 in a Huntington\u2019s disease-like rat model. Brain Stimul 6:84\u201386","journal-title":"Brain Stimul"},{"key":"9609_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0006-8993(02)03488-1","volume":"956","author":"M Mogami","year":"2002","unstructured":"Mogami M, Hida H, Hayashi Y, Kohri K, Kodama Y, Gyun Jung C, Nishino H (2002) Estrogen blocks 3-nitropropionic acid-induced Ca2+i increase and cell damage in cultured rat cerebral endothelial cells. Brain Res 956:116\u2013125","journal-title":"Brain Res"},{"key":"9609_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0168-0102(98)00010-8","volume":"30","author":"H Nishino","year":"1998","unstructured":"Nishino H, Nakajima K, Kumazaki M, Fukuda A, Muramatsu K, Deshpande SB, Inubushi T, Morikawa S, Borlongan CV, Sanberg PR (1998) Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid. Neurosci Res 30:303\u2013312","journal-title":"Neurosci Res"},{"key":"9609_CR43","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/jnr.20138","volume":"77","author":"MT Tebano","year":"2004","unstructured":"Tebano MT, Pintor A, Frank C, Domenici MR, Martire A, Pepponi R, Potenza RL, Grieco R, Popoli P (2004) Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum. J Neurosci Res 77:100\u2013107","journal-title":"J Neurosci Res"},{"key":"9609_CR44","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.neuropharm.2004.01.008","volume":"46","author":"K Wirkner","year":"2004","unstructured":"Wirkner K, Gerevich Z, Krause T, Gunther A, Koles L, Schneider D, Norenberg W, Illes P (2004) Adenosine A2A receptor-induced inhibition of NMDA and GABAA receptor-mediated synaptic currents in a subpopulation of rat striatal neurons. Neuropharmacology 46:994\u20131007","journal-title":"Neuropharmacology"},{"key":"9609_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/00004647-200001000-00016","volume":"20","author":"GW Kim","year":"2000","unstructured":"Kim GW, Copin JC, Kawase M, Chen SF, Sato S, Gobbel GT, Chan PH (2000) Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid. J Cereb Blood Flow Metab 20:119\u2013129","journal-title":"J Cereb Blood Flow Metab"},{"key":"9609_CR46","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.expneurol.2006.07.009","volume":"202","author":"D Centonze","year":"2006","unstructured":"Centonze D, Prosperetti C, Barone I, Rossi S, Picconi B, Tscherter A, De Chiara V, Bernardi G, Calabresi P (2006) NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum. Exp Neurol 202:470\u2013479","journal-title":"Exp Neurol"},{"key":"9609_CR47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/jnr.20150","volume":"77","author":"SH Ramirez","year":"2004","unstructured":"Ramirez SH, Fan S, Maguire CA, Perry S, Hardiek K, Ramkumar V, Gelbard HA, Dewhurst S, Maggirwar SB (2004) Activation of adenosine A2A receptor protects sympathetic neurons against nerve growth factor withdrawal. J Neurosci Res 77:258\u2013269","journal-title":"J Neurosci Res"},{"key":"9609_CR48","doi-asserted-by":"publisher","first-page":"15388","DOI":"10.1523\/JNEUROSCI.0558-13.2013","volume":"33","author":"S Visentin","year":"2013","unstructured":"Visentin S, De Nuccio C, Bernardo A, Pepponi R, Ferrante A, Minghetti L, Popoli P (2013) The stimulation of adenosine A2A receptors ameliorates the pathological phenotype of fibroblasts from Niemann-Pick type C patients. J Neurosci 33:15388\u201315393","journal-title":"J Neurosci"},{"key":"9609_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neuropharm.2015.11.022","volume":"103","author":"A Ferrante","year":"2016","unstructured":"Ferrante A, De Nuccio C, Pepponi R, Visentin S, Martire A, Bernardo A, Minghetti L, Popoli P (2016) Stimulation of adenosine A2A receptors reduces intracellular cholesterol accumulation and rescues mitochondrial abnormalities in human neural cell models of Niemann-Pick C1. Neuropharmacology 103:155\u2013162","journal-title":"Neuropharmacology"},{"key":"9609_CR50","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.pharep.2014.07.006","volume":"66","author":"J Mishra","year":"2014","unstructured":"Mishra J, Kumar A (2014) Improvement of mitochondrial NAD(+)\/FAD(+)-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: implications in Huntington\u2019s disease. Pharmacol Rep 66:1148\u20131155","journal-title":"Pharmacol Rep"},{"key":"9609_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/321168a0","volume":"321","author":"MF Beal","year":"1986","unstructured":"Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB (1986) Replication of the neurochemical characteristics of Huntington\u2019s disease by quinolinic acid. Nature 321:168\u2013171","journal-title":"Nature"},{"key":"9609_CR52","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/jnc.13724","volume":"139","author":"RA Cunha","year":"2016","unstructured":"Cunha RA (2016) How does adenosine control neuronal dysfunction and neurodegeneration? J Neurochem 139:1019\u20131055","journal-title":"J Neurochem"},{"key":"9609_CR53","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1093\/hmg\/ddp230","volume":"18","author":"MC Chiang","year":"2009","unstructured":"Chiang MC, Chen HM, Lai HL, Chen HW, Chou SY, Chen CM, Tsai FJ, Chern Y (2009) The A2A adenosine receptor rescues the urea cycle deficiency of Huntington\u2019s disease by enhancing the activity of the ubiquitin-proteasome system. Hum Mol Genet 18:2929\u20132942","journal-title":"Hum Mol Genet"},{"issue":"6","key":"9609_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020934","volume":"6","author":"NK Huang","year":"2011","unstructured":"Huang NK, Lin JH, Lin JT, Lin CI, Liu EM, Lin CJ, Chen WP, Shen YC, Chen HM, Chen JB, Lai HL, Yang CW, Chiang MC, Wu YS, Chang C, Chen JF, Fang JM, Lin YL, Chern Y (2011) A new drug design targeting the adenosinergic system for Huntington\u2019s disease. PLoS One 6(6):e20934","journal-title":"PLoS One"},{"key":"9609_CR55","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuropharm.2015.08.009","volume":"99","author":"AH Chou","year":"2015","unstructured":"Chou AH, Chen YL, Chiu CC, Yuan SJ, Weng YH, Yeh TH, Lin YL, Fang JM, Wang HL (2015) T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse. Neuropharmacology 99:308\u2013317","journal-title":"Neuropharmacology"},{"key":"9609_CR56","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1046\/j.1471-4159.2003.02145.x","volume":"88","author":"JS Fink","year":"2004","unstructured":"Fink JS, Kalda A, Ryu H, Stack EC, Schwarzschild MA, Chen JF, Ferrante RJ (2004) Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage. J Neurochem 88:538\u2013544","journal-title":"J Neurochem"},{"key":"9609_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nbd.2015.03.030","volume":"79","author":"W Li","year":"2015","unstructured":"Li W, Silva HB, Real J, Wang YM, Rial D, Li P, Payen MP, Zhou Y, Muller CE, Tom\u00e9 AR, Cunha RA, Chen JF (2015) Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington\u2019s disease models. Neurobiol Dis 79:70\u201380","journal-title":"Neurobiol Dis"},{"key":"9609_CR58","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/sj.bjp.0704712","volume":"136","author":"M Marchi","year":"2002","unstructured":"Marchi M, Raiteri L, Risso F, Vallarino A, Bonfanti A, Monopoli A, Ongini E, Raiteri M (2002) Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes. Br J Pharmacol 136:434\u2013440","journal-title":"Br J Pharmacol"},{"key":"9609_CR59","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11302-015-9476-1","volume":"11","author":"SH Vaz","year":"2015","unstructured":"Vaz SH, L\u00e9rias SR, Parreira S, Di\u00f3genes MJ, Sebasti\u00e3o AM (2015) Adenosine A2A receptor activation is determinant for BDNF actions upon GABA and glutamate release from rat hippocampal synaptosomes. Purinergic Signal 11:607\u2013612","journal-title":"Purinergic Signal"},{"key":"9609_CR60","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181\u20134192","journal-title":"J Neurosci"},{"key":"9609_CR61","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1046\/j.1471-4159.1999.0720129.x","volume":"72","author":"MR S\u00e1nchez-Carbente","year":"1999","unstructured":"S\u00e1nchez-Carbente MR, Massieu L (1999) Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired. J Neurochem 72:129\u2013138","journal-title":"J Neurochem"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11302-018-9609-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-018-9609-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-018-9609-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T15:38:39Z","timestamp":1751643519000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11302-018-9609-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["9609"],"URL":"https:\/\/doi.org\/10.1007\/s11302-018-9609-4","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]},"assertion":[{"value":"29 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}